Literature DB >> 30532684

Criteria for specific measurement of plasminogen (enzymatic; procedure) in human plasma.

Johannes J Sidelmann1, Nuala A Booth2, Johannes Hoffmann3, Michael E Nesheim4, Steffen Rosén5.   

Abstract

There is a lack of well-established criteria for the specific measurement of fibrinolytic variables. On behalf of the SSC the Subcommittee on Fibrinolysis started a process to develop such criteria. This report describes the criteria for the measurement of plasminogen (enzymatic; procedure) in human plasma. Apparently, the most specific methods for determination of plasminogen (enzymatic; procedure) adhere to the principle of streptokinase induced activation of plasminogen and recording of activity using a chromogenic substrate. Incorporation of fibrinogen attenuates the potential effect of elevated fibrinogen or fibrin(ogen) fragments in the plasma sample. The criteria for specific measurement of plasminogen(enzymatic; procedure) are based on this analytical principle. The kinetics and principles of the assay procedure are described, and criteria as well as test methods for criteria are detailed. Guidelines for standardization, quality assurance, analytical sensitivity and establishment of reference intervals are given. The pre-analytical conditions regarding preparation of the patient and the specimen are delineated. Nonstandard abbreviations: SSC, Scientific and Standardization Committee; ISTH, The International Society on Thrombosis and Haemostasis; IFCC, The International Federation of Clinical Chemistry; NCCLS, National Center for Clinical Laboratory Standards; HRG, histidine-rich glycoprotein; Lp(a), lipoprotein (a); SK, streptokinase.

Entities:  

Year:  2000        PMID: 30532684      PMCID: PMC6282604     

Source DB:  PubMed          Journal:  EJIFCC        ISSN: 1650-3414


  23 in total

1.  Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site.

Authors:  M Gonzalez-Gronow; J M Edelberg; S V Pizzo
Journal:  Biochemistry       Date:  1989-03-21       Impact factor: 3.162

2.  On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasmin.

Authors:  B Wiman
Journal:  Thromb Res       Date:  1980 Jan 1-15       Impact factor: 3.944

3.  International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values.

Authors:  H E Solberg; C PetitClerc
Journal:  J Clin Chem Clin Biochem       Date:  1988-09

4.  Linkage disequilibrium of plasminogen polymorphisms and assignment of the gene to human chromosome 6q26-6q27.

Authors:  J C Murray; K H Buetow; M Donovan; S Hornung; A G Motulsky; C Disteche; K Dyer; K Swisshelm; J Anderson; E Giblett
Journal:  Am J Hum Genet       Date:  1987-04       Impact factor: 11.025

5.  A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.

Authors:  J Gram; J Jespersen
Journal:  Thromb Haemost       Date:  1985-04-22       Impact factor: 5.249

6.  Human homozygous type I plasminogen deficiency and ligneous conjunctivitis.

Authors:  A M Mingers; A Philapitsch; P Zeitler; V Schuster; H P Schwarz; H W Kreth
Journal:  APMIS       Date:  1999-01       Impact factor: 3.205

7.  Prevention of in vitro fibrinogenolysis during laboratory monitoring of thrombolytic therapy with streptokinase or APSAC.

Authors:  J J Hoffmann; M Vijgen
Journal:  Blood Coagul Fibrinolysis       Date:  1991-04       Impact factor: 1.276

8.  Isolated familial plasminogen deficiency may not be a risk factor for thrombosis.

Authors:  R C Tait; I D Walker; J A Conkie; S I Islam; F McCall
Journal:  Thromb Haemost       Date:  1996-12       Impact factor: 5.249

9.  Treatment of hereditary protein C deficiency with stanozolol.

Authors:  A W Broekmans; J Conard; R G van Weyenberg; M H Horellou; C Kluft; R M Bertina
Journal:  Thromb Haemost       Date:  1987-02-03       Impact factor: 5.249

10.  Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults.

Authors:  C Kluft; F E Preston; R G Malia; R M Bertina; G Wijngaards; M Greaves; J H Verheijen; G Dooijewaard
Journal:  Thromb Haemost       Date:  1984-04-30       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.